PortfoliosLab logoPortfoliosLab logo
XTNT vs. NUTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

XTNT vs. NUTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Xtant Medical Holdings, Inc. (XTNT) and Nutex Health Inc (NUTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XTNT achieves a -45.18% return, which is significantly lower than NUTX's -10.44% return.


XTNT

1D
-0.60%
1M
4.09%
6M
-27.40%
YTD
-45.18%
1Y
-23.25%
3Y*
-25.75%
5Y*
-18.97%
10Y*
-31.78%
ALL TIME*
-34.17%

NUTX

1D
-0.86%
1M
-24.98%
6M
-0.91%
YTD
-10.44%
1Y
75.51%
3Y*
34.96%
5Y*
10Y*
ALL TIME*
-42.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$17.86M$21.25M$20.00M
$19.46K$40.63K$51.90K

XTNT vs. NUTX - Yearly Performance Comparison


2026 (YTD)2025202420232022
XTNT
Xtant Medical Holdings, Inc.
-45.18%76.98%-60.80%71.21%-5.71%
NUTX
Nutex Health Inc
-10.44%419.47%17.37%-90.53%-81.82%

Correlation

The correlation between XTNT and NUTX is 0.11, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.11

Correlation (3Y)
Balances recent behavior with more history.

0.09

Correlation (All Time)
Calculated using the full available price history since Apr 4, 2022

0.06

Fundamentals

Market Cap

XTNT:

$60.29M

NUTX:

$1.01B

EPS

XTNT:

$0.12

NUTX:

$20.14

PE Ratio

XTNT:

3.56

NUTX:

7.32

PS Ratio

XTNT:

0.24

NUTX:

0.80

Total Revenue (TTM)

XTNT:

$133.93M

NUTX:

$879.95M

Gross Profit (TTM)

XTNT:

$84.27M

NUTX:

$417.67M

EBITDA (TTM)

XTNT:

$22.15M

NUTX:

$275.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XTNT vs. NUTX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

XTNT
XTNT Risk / Return Rank: 2727
Overall Rank
XTNT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
XTNT Sortino Ratio Rank: 2525
Sortino Ratio Rank
XTNT Omega Ratio Rank: 2626
Omega Ratio Rank
XTNT Calmar Ratio Rank: 2929
Calmar Ratio Rank
XTNT Martin Ratio Rank: 3030
Martin Ratio Rank

NUTX
NUTX Risk / Return Rank: 7171
Overall Rank
NUTX Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
NUTX Sortino Ratio Rank: 7373
Sortino Ratio Rank
NUTX Omega Ratio Rank: 7272
Omega Ratio Rank
NUTX Calmar Ratio Rank: 7272
Calmar Ratio Rank
NUTX Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

XTNT vs. NUTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtant Medical Holdings, Inc. (XTNT) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XTNTNUTXDifference
Sharpe ratioReturn per unit of total volatility

-1.26

Sortino ratioReturn per unit of downside risk

-1.98

Omega ratioGain probability vs. loss probability

0.96

1.20

-0.24

Calmar ratioReturn relative to maximum drawdown

-0.44

1.37

-1.80

Martin ratioReturn relative to average drawdown

-0.73

2.68

-3.41

XTNT vs. NUTX - Sharpe Ratio Comparison

The current XTNT Sharpe Ratio is -0.44, which is lower than the NUTX Sharpe Ratio of 0.81. The chart below compares the historical Sharpe Ratios of XTNT and NUTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XTNT vs. NUTX - Drawdown Comparison

The maximum XTNT drawdown since its inception was -99.17%, roughly equal to the maximum NUTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for XTNT and NUTX.


Loading charts...

Drawdown Indicators


XTNTNUTXDifference

Max Drawdown

Largest peak-to-trough decline

-99.17%

-99.93%

+0.76%

Max Drawdown (1Y)

Largest decline over 1 year

-57.61%

-54.32%

-3.29%

Max Drawdown (3Y)

Largest decline over 3 years

-74.78%

-92.39%

+17.61%

Max Drawdown (5Y)

Largest decline over 5 years

-74.78%

Max Drawdown (10Y)

Largest decline over 10 years

-98.43%

Current Drawdown

Current decline from peak

-98.98%

-97.54%

-1.44%

Average Drawdown

Average peak-to-trough decline

-88.90%

-97.19%

+8.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.50%

27.59%

+6.91%

Volatility

XTNT vs. NUTX - Volatility Comparison

Xtant Medical Holdings, Inc. (XTNT) has a higher volatility of 17.71% compared to Nutex Health Inc (NUTX) at 15.79%. This indicates that XTNT's price experiences larger fluctuations and is considered to be riskier than NUTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XTNTNUTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.71%

15.79%

+1.92%

Volatility (6M)

Calculated over the trailing 6-month period

34.46%

60.57%

-26.11%

Volatility (1Y)

Calculated over the trailing 1-year period

56.75%

91.11%

-34.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.33%

189.30%

-117.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

113.48%

189.30%

-75.82%

Dividends

XTNT vs. NUTX - Dividend Comparison

Neither XTNT nor NUTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

XTNT vs. NUTX - Financials Comparison

This section allows you to compare key financial metrics between Xtant Medical Holdings, Inc. and Nutex Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

XTNT vs. NUTX - Profitability Comparison

The chart below illustrates the profitability comparison between Xtant Medical Holdings, Inc. and Nutex Health Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

XTNT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Xtant Medical Holdings, Inc. reported a gross profit of 17.75M and revenue of 32.36M. Therefore, the gross margin over that period was 54.9%.

NUTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nutex Health Inc reported a gross profit of 91.73M and revenue of 216.49M. Therefore, the gross margin over that period was 42.4%.

XTNT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Xtant Medical Holdings, Inc. reported an operating income of -944.00K and revenue of 32.36M, resulting in an operating margin of -2.9%.

NUTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nutex Health Inc reported an operating income of 81.27M and revenue of 216.49M, resulting in an operating margin of 37.5%.

XTNT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Xtant Medical Holdings, Inc. reported a net income of 4.06M and revenue of 32.36M, resulting in a net margin of 12.6%.

NUTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nutex Health Inc reported a net income of 46.81M and revenue of 216.49M, resulting in a net margin of 21.6%.


Frequently Asked Questions


XTNT and NUTX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XTNT has higher volatility (17.71%) compared to NUTX (15.79%). In terms of maximum drawdown, XTNT dropped -99.17% vs NUTX's -99.93%.

NUTX currently has the higher Sharpe Ratio (0.81 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XTNT and NUTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer